Brought to you by 
Megabios to acquire GeneMedicine Inc. for $38mm in stock
29 Aug 2001
Executive Summary
Megabios (MBIO) has agreed to acquire GeneMedicine for about $38.1mm in stock. The combined company will have seven products in clinical development, three of which are in Phase II, and partnerships with four major drug makers.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Megabios to acquire GeneMedicine Inc. for $38mm in stock
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice